Carri Duncan
Director/Board Member at eureKING SA
Network origin in Carri Duncan first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
eureKING SA
 eureKING SA Financial ConglomeratesFinance eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France.
13
| Private Company | Financial Conglomerates | 13 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Carri Duncan via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Chief Operating Officer | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| SOCIÉTÉ GÉNÉRALE | Regional Banks | Corporate Officer/Principal | |
Credit Suisse Asset Management Ltd.
 Credit Suisse Asset Management Ltd. Investment ManagersFinance Credit Suisse Asset Management Ltd. (CSAM) is the wholly-owned, Great Britain-based asset management subsidiary of Credit Suisse Asset Management (UK) Holding Ltd., itself a subsidiary of Credit Suisse Group AG (SWX: CSGN, NYSE: CS) in Switzerland. Founded in 1982, the firm is headquartered in London and offers a wide range of investment products and functions across asset classes and investment styles for various clients including governments, institutions, corporations and private individuals. | Investment Managers | Analyst-Equity | |
Threadneedle Asset Management Ltd.
 Threadneedle Asset Management Ltd. Investment ManagersFinance Threadneedle Asset Management Ltd. (Threadneedle AM) is the wholly-owned global asset management subsidiary of TC Financing Ltd., ultimately held by Ameriprise Financial, Inc. (NYSE: AMP) in the US. Headquartered in London, the firm was founded in 1994 and manages assets for a range of clients which includes pension schemes, insurance companies, private investors and corporations. Threadneedle AM is a socially responsible investor which believes they have a responsibility to, and will benefit from, exercising environmental and social stewardship throughout their firm. | Investment Managers | Portfolio Manager-Equities | |
| Imperial College London | College/University | Doctorate Degree | |
| University of Birmingham | College/University | Undergraduate Degree | |
| ESCP Europe Campus Paris | College/University | Undergraduate Degree | |
| Universität Ulm | College/University | Doctorate Degree | |
Ernst & Young Audit SAS (France)
 Ernst & Young Audit SAS (France) Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young Audit SAS (France) is a French company that provides auditing and accounting services. The company is based in Courbevoie, France. Founded in 1987. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Laboratoire Français du Fractionnement et des Biotechnologies
 Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Biotechnology | Director/Board Member | |
French Academy of Sciences
 French Academy of Sciences Other Consumer ServicesConsumer Services French Academy of Sciences engages in protection of spirit of French scientific research. The firm offers science teaching, transmitting knowledge, international collaboration and advice. The company was founded by Jean-Baptiste Colbert in 1666 and is headquartered in Paris, France. | Other Consumer Services | Corporate Officer/Principal | |
INSERM Transfert Initiative SAS
 INSERM Transfert Initiative SAS Investment ManagersFinance INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages. | Investment Managers | Director/Board Member | |
| AB SCIENCE | Pharmaceuticals: Other | Corporate Officer/Principal | |
Compas SA
 Compas SA Wholesale DistributorsDistribution Services Compas SA wholesales chemical products. The company was founded on April, 19 1949 and is headquartered in Gueux, France. | Wholesale Distributors | Director/Board Member | |
Edwards Lifesciences SAS
 Edwards Lifesciences SAS Medical DistributorsDistribution Services Part of Edwards Lifesciences Corp., Edwards Lifesciences SAS is a French company that engages in wholesale distribution of pharmaceutical products. The company is based in Guyancourt, France. | Medical Distributors | Chief Executive Officer | |
Cross Current Research LLC
 Cross Current Research LLC Investment ManagersFinance Founded in 2009 by Dr. Alex To, Cross Current Research LLC is an independent research firm located in Skillman, New Jersey. The firm offers comprehensive fundamental industry and company-specific research, as well as technical analysis of stocks and markets. They cover the healthcare, technology and financial services sectors. Cross Current Research offers services to institutional investors. | Investment Managers | Analyst-Equity | |
| Institut d'Etudes Politiques de Lille | College/University | Undergraduate Degree | |
| École Supérieure de Chimie Physique Électronique | College/University | Undergraduate Degree | |
| Sorbonne Université | College/University | Masters Business Admin | |
Da Volterra SA
 Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Biotechnology | Corporate Officer/Principal | |
| CARBIOS | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| THERANEXUS | Pharmaceuticals: Major | Director/Board Member | |
BioAster
 BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| PHC HOLDINGS CORPORATION | Medical Specialties | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| IAE Lyon School of Management | College/University | Graduate Degree | |
Famar Health Care Services
 Famar Health Care Services Medical/Nursing ServicesHealth Services Famar Health Care Services is a Greek European company that specializes in pharmaceutical manufacturing and development services. The company is based in Athens, Greece. With a legacy of 70 years of technology expertise, Famar is a leading provider in the industry. and has subsidiaries in Spain. Kostas Rengis has been the CEO of the company since 2021. | Medical/Nursing Services | Corporate Officer/Principal | |
Bayer Healthcare SAS
 Bayer Healthcare SAS Pharmaceuticals: MajorHealth Technology Bayer Healthcare SAS manufactures pharmaceutical products. The company was founded on July 23, 2007 and is headquartered in Loos, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ascensia Diabetes Care Holdings AG
 Ascensia Diabetes Care Holdings AG Medical SpecialtiesHealth Technology Part of PHC Holdings Corp., Ascensia Diabetes Care Holdings AG delivers products and solutions for people with diabetes. The company is based in Basel, Switzerland and was founded in 2016. | Medical Specialties | Chairman | |
Ascensia Diabetes Care France SAS
 Ascensia Diabetes Care France SAS Electronic Equipment/InstrumentsElectronic Technology Part of PHC Holdings Corp., Ascensia Diabetes Care France SAS is a French company that manufactures glycemic self-monitoring devices for people with diabetes. The company is based in Neuilly-sur-Seine, France. | Electronic Equipment/Instruments | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Stellate Therapeutics SAS
 Stellate Therapeutics SAS BiotechnologyHealth Technology Stellate Therapeutics, Inc. provides micro biome medicine. It also offers therapeutic products and associated diagnosis tools. The company was founded by Antoine Danchin and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Mckesson Belgium Holdings SRL
 Mckesson Belgium Holdings SRL Financial ConglomeratesFinance Part of McKesson Europe AG, Mckesson Belgium Holdings SRL is an investment holding Belgian company. The company is based in Wavre, Belgium. Hubert Olivier has been the CEO of the company since 2012. | Financial Conglomerates | Chief Executive Officer | |
Versameb AG
 Versameb AG Miscellaneous Commercial ServicesCommercial Services Versameb AG operates as an preclinical-stage biopharmaceutical company. The company was founded by Friedrich Metzger, Roger Meier and Urs Breitenstein in 2018 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Inserm-Transfert SA
 Inserm-Transfert SA Miscellaneous Commercial ServicesCommercial Services Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Université Paris-Saclay | College/University | Graduate Degree | |
| Omne Possibile | Director/Board Member Director/Board Member Founder | ||
eureKARE SA
 eureKARE SA BiotechnologyHealth Technology eureKARE SA is a start-up studio that specializes in synthetic biology. The private company is based in Senningerberg, Luxembourg. The Luxembourger company identifies opportunities and needs in areas including health, environment, sustainability, and biomanufacturing. The company's scientists use engineering techniques to modify and improve biological components like living cells. The company catalyzes their innovations into successful businesses with access to funding and the right resources. The company was founded by Alexandre Mouradian, Rodolphe Besserve, Bénédicte Garbil, and Alexandre Mouradian has been the CEO since incorporation. | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal Founder | |
Meletios Therapeutics SAS
 Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Linkinvax SA
 Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
| Pharmuka Laboratory | Corporate Officer/Principal | ||
| Nippon International Strategic Advisory LLC | Chief Executive Officer | ||
| Novachim SA | Corporate Officer/Principal | ||
| Muiscare SAS | Chairman | ||
| Spinoza Foundation | Chairman | ||
| eureKASYNBIO SRL | Director/Board Member | ||
Back to Basics, Inc.
 Back to Basics, Inc. Food RetailRetail Trade Back to Basics, Inc. is an American company that is currently open for business. The private company prioritizes the safety of their staff and their families, especially those who are in high-risk groups. Customers are required to wear masks when entering the store. | Food Retail | Director/Board Member Director/Board Member |
Statistics
International
| France | 30 |
| United Kingdom | 6 |
| United States | 5 |
| Switzerland | 4 |
| Japan | 3 |
Sectoral
| Health Technology | 16 |
| Consumer Services | 11 |
| Finance | 7 |
| Commercial Services | 7 |
| Distribution Services | 3 |
Operational
| Director/Board Member | 44 |
| Corporate Officer/Principal | 24 |
| Chairman | 15 |
| Chief Executive Officer | 12 |
| Founder | 11 |
Most connected contacts
- Stock Market
- Insiders
- Carri Duncan
- Company connections
